Viking Therapeutics, Inc. (VKTX)
30.89
+0.21
(+0.68%)
USD |
NASDAQ |
May 22, 16:00
30.86
-0.03
(-0.10%)
After-Hours: 20:00
Viking Therapeutics EPS Diluted (Quarterly) : -1.37 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| Amgen, Inc. | 3.344 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Altimmune, Inc. | -0.1813 |
| TG Therapeutics, Inc. | 0.1236 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -158.32M |
| Total Expenses (Quarterly) | 158.32M |
| Enterprise Value | 2.984B |
| Earnings Yield | -13.42% |
| Normalized Earnings Yield | -13.42 |